CHAIRMAN

Richard Glickman, PhD


  • Former co-founder and CEO of Aspreva Pharmaceuticals
    (acquired for ~$1B in 5yrs from start-up) and Stressgen

  • Current CEO/Director at Aurinia Pharmaceuticals

  • Venture Partner at Lumira Ventures